Zalutumumab (EGFR) - Research Grade Biosimilar

Zalutumumab is a fully human IgG1 monoclonal antibody designed to bind with selectivity to the epidermal growth factor receptor (EGFR) . Zalutumumab has been investigated for the treatment of Squamous Cell Cancer and Head and Neck Cancer.

Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8 ˚ C for 1-2 weeks. Store at -20 ˚ C for 12 months. Store at -80 ˚ C for long term storage.